CVR 33776748Public limited company (A/S)Fremstilling af farmaceutiske præparater (212000)TylstrupFounded 1 Jul 2011
Employees
1
CVR registry, 2022
Gross profit
169.4K
DKK, annual report 2025
Result
+106.2K
DKK, annual report 2025
Equity
124.3K
DKK, annual report 2025
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about SALIXIN A/S, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexNy Vraa A/SCVR 43359037, 100% of capital and votes, since 20 Dec 2024
Allan Juul Bechsince 23 Sep 2026
Equity of 124.3K DKK was below half the share capital of 780.4K DKK at 31 Dec 2025. Under the Companies Act (selskabsloven § 119) management must then account for the company's finances at a general meeting. Dandex estimate, computed 2 Nov 2026.
CVR 43359037100% of capital and votessince 20 Dec 2024
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
CVR 3141872033.3% to under 50% of capital and votes18 Feb 2022 to 20 Dec 2024
CVR 3234218333.3% to under 50% of capital and votes6 Jan 2014 to 20 Dec 2024
CVR 3244963820% to under 25% of capital and votes6 Jan 2014 to 1 Nov 2021
CVR 3670637620% to under 25% of capital and votes1 Nov 2021 to 1 Nov 2023
CVR 3711343310% to under 15% of capital and votes19 Sep 2017 to 1 Nov 2021
CVR 4255882620% to under 25% of capital and votes7 Jul 2023 to 20 Dec 2024
CVR records founders at incorporation. It does not record whether they are alive or still involved.
24 Mar 2022 to 2 Nov 2026.
1 Jul 2011 to 2 Nov 2026.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Gross profit | 9,103 | 496 | -286 | -346 | 169 |
| Operating profit | +8,294 | +250 | -9,210 | -638 | +128 |
| Result for the year | +6,345 | +55 | -8,534 | +1,052 | +106 |
| Equity | 3,895 | 3,950 | -1,033 | 18 | 124 |
| Total assets | 9,825 | 9,810 | 2,004 | 711 | 1,218 |
| Employees (average) | 2 | 1 | 1 | 0 | 0 |
| Credit metrics (Dandex calculations) | |||||
| Gross profit growth (vækst i bruttofortjeneste) | 12,847.8% | 178.5% | -157.5% | n.m.note 1 | n.m.note 1 |
| EBITDA | 8,383 | 341 | -8,960 | -596 | 169 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) | 92.1% | 68.7% | n.m.note 2 | n.m.note 2 | 100% |
| Employee growth (vækst i antal ansatte) | 0% | -50% | 0% | n.m.note 1 | n.m.note 1 |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | 1,336 | 1,379 | -871 | -329 | -293 |
| Gearing, NIBD / EBITDA | 0.2x | 4x | n.m.note 3 | n.m.note 3 | Net cash |
| ROIC (afkast af investeret kapital) | 323.3% | 3.7% | -419.5%note 4 | n.m.note 5 | n.m.note 5 |
| Capex (investeringer i anlægsaktiver) | 46note 6 | 58note 7 | Not reportednote 8 | Not reportednote 8 | 0note 6 |
| NIBD incl. group and owner balances (NIBD inkl. koncern- og ejermellemværender) | 4,927 | 3,699 | 1,446 | -329 | 233 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may. No cash flow statement filed (class A and B are exempt).
Annual report 2025
1 Jan 2025 to 31 Dec 2025, published 25 Jun 2026
Annual report 2024
1 Jan 2024 to 31 Dec 2024, published 17 Jun 2025
Annual report 2023
1 Jan 2023 to 31 Dec 2023, published 10 Jun 2024
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 7 Jul 2023
Annual report 2021
1 Jan 2021 to 31 Dec 2021, published 5 Apr 2022
SALIXIN A/S has new leadership, a good time to reach out.
Signal, a Dandex estimate. Lapses 1 Jan 2027.
SALIXIN A/S has changed ownership. A new strategy and new needs can be expected.
Signal, a Dandex estimate. Lapses 30 Jan 2027.
1 registered in CVR.
P-number 1016969431Gammel Vråvej 31, 9382 Tylstrup
